CALABASAS, Calif. - NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a clinical-stage biotech company with a current market capitalization of $113.3 million, announced Thursday that its board of ...

NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment Jul. 10, 2025 9:00 AM ET NeOnc Technologies Holdings, Inc. (NTHI) ...

NeOnc Technologies Holdings, Inc. announced a significant step towards finalizing its strategic investment deal with Quazar Investment, receiving formal approval from its Board of Directors for a ...

In other recent news, NeOnc Technologies Holdings Inc. has signed a non-binding term sheet with Quazar Investment for a $50 million equity investment aimed at expanding its clinical trials in the ...

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform ...

CALABASSAS, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous ...

NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to ...